NumerixS Investment Technologies’s ResMed RMD Stock Holding History

NumerixS Investment Technologies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,800	Closed	-$288K	–	1305
2019 Q1	$288K	Buy	+2,800	New	+$289K	0.04%	548
2017 Q4	–	Sell	-6,000	Closed	-$462K	–	1325
2017 Q3	$462K	Buy	6,000 +3,800	+173%	+$291K	0.1%	248
2017 Q2	$171K	Sell	2,200 -15,118	-87%	-$1.08M	0.03%	690
2017 Q1	$1.25M	Sell	17,318 -4,002	-19%	-$277K	0.14%	171
2016 Q4	$1.32M	Buy	21,320 +16,420	+335%	+$1.01M	0.17%	146
2016 Q3	$317K	Sell	4,900 -3,486	-42%	-$232K	0.04%	527
2016 Q2	$530K	Sell	8,386 -18,358	-69%	-$1.08M	0.07%	373
2016 Q1	$1.55M	Buy	26,744 +18,944	+243%	+$1.07M	0.18%	141
2015 Q4	$419K	Buy	+7,800	New	+$440K	0.05%	484

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NumerixS Investment Technologies's RMD Position: Q2 2019 in Review

NumerixS Investment Technologies sold out of ResMed (RMD) in Q2 2019, closing a stake of 2,800 shares — an estimated $288K sold.

NumerixS Investment Technologies first reported a position in RMD in Q4 2015 and held it in 9 quarters. The position peaked at $1.55M in Q1 2016. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

NumerixS Investment Technologies reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
NumerixS Investment Technologies sold 2,800 ResMed shares in Q2 2019, an estimated $288K.
NumerixS Investment Technologies first reported a position in ResMed in Q4 2015 and held it in 9 quarters.
NumerixS Investment Technologies's ResMed position peaked at $1.55M in Q1 2016.
485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on NumerixS Investment Technologies's 13F filing for Q2 2019, filed 13 Aug 2019.